UnitedHealth raises 2026 profit outlook as medical cost pressures ease

UnitedHealth Group reported stronger-than-expected third-quarter 2026 adjusted earnings of $4.69 per share and raised its full-year profit forecast to at least $20.50 per share. The medical cost ratio improved to 88.4%, supported by product repricing, membership reductions in Medicare Advantage, and shift toward lower-cost home healthcare settings. Under returning CEO Stephen Hemsley, the company continues its recovery following operational disruptions, missed earnings targets, and a major cyberattack in 2025.

Full-year 2026 earnings outlook

• ▪The full-year 2026 profit outlook increase marks the third time UnitedHealth Group has raised its annual guidance during 2026
• ▪UnitedHealth Group raised its full-year 2026 adjusted earnings per share outlook to at least $20.50, up from its previous 2026 projection of $19.50 to $20.00

Fiscal 2027 growth outlook

• ▪UnitedHealth Group CFO Wayne DeVeydt stated that the lower end of the company's long-term earnings growth rate projection of 13% to 16% is a reasonable starting point for fiscal 2027
• ▪UnitedHealth Group CFO Wayne DeVeydt stated that current analyst consensus estimates of $22.61 per share for fiscal 2027 may understate the company's growth opportunity

Q3 2026 financial results

• ▪UnitedHealth Group reported third-quarter 2026 adjusted earnings of $4.69 per share on revenue of $112.69 billion, exceeding Wall Street expectations of $4.14 per share on $111.40 billion in revenue
• ▪UnitedHealth Group posted third-quarter 2026 net income of $4.11 billion, or $4.56 per share, compared to $2.35 billion, or $2.59 per share, in the prior-year quarter

Medical cost ratio improvements

• ▪UnitedHealth Group's third-quarter 2026 medical cost ratio fell to 88.4% from 89.9% in the prior-year period, beating analyst expectations of 89.9%
• ▪UnitedHealth Group's medical cost ratio was reduced by a $610 million reserve benefit resulting from lower-than-expected medical cost claims for services rendered earlier in 2026

Drivers of medical cost pressures

• ▪UnitedHealth Group CFO Wayne DeVeydt stated that costs for inpatient services and specialty pharmacy drugs for cancer and rare diseases remain elevated
• ▪UnitedHealth Group CFO Wayne DeVeydt stated that the Independent Dispute Resolution process under the No Surprises Act, which took effect in 2022, adds at least 100 basis points to total medical costs

Patient care and operational trends

• ▪UnitedHealth Group members saw a 15% year-over-year decrease in acute hospital admissions and a 10% increase in home health admissions through third-quarter 2026
• ▪UnitedHealth Group CFO Wayne DeVeydt stated that patient-driven appointment scheduling completed without provider assistance increased 27% year over year

UnitedHealthcare insurance unit performance

• ▪Since the end of 2025, 935,000 members have exited UnitedHealth Group's Medicare Advantage business, while third-quarter employer-sponsored plan membership fell by 165,000 and Medicaid enrollment fell by 85,000
• ▪Third-quarter revenue from UnitedHealth Group's UnitedHealthcare insurance business fell to $86.3 billion from $87.1 billion in the prior-year period

Turnaround after 2025 crisis

• ▪Stephen Hemsley returned as Chief Executive Officer of UnitedHealth Group to oversee structural changes and cost control measures following the company's 2025 financial decline linked to a major cyberattack
• ▪UnitedHealth Group's two-year turnaround follows a financial crisis in 2025 caused by a major cyberattack, missed earnings targets, and the killing of a top executive outside its investor meeting in New York nearly two years ago